By Helgi Library - April 2, 2020
Merck Czech Republic's total assets reached CZK 774 mil at the end of 2017, up 6.64% compared to the previous year. ...
By Helgi Library - April 2, 2020
Merck Czech Republic's total assets reached CZK 774 mil at the end of 2017, up 6.64% compared to the previous year. ...
| Profit Statement | 2015 | 2016 | 2017 | |
| Sales | CZK mil | 1,850 | 1,821 | 1,818 |
| Gross Profit | CZK mil | 263 | 228 | 251 |
| EBITDA | CZK mil | 95.9 | 60.9 | 72.8 |
| EBIT | CZK mil | 94.7 | 59.5 | 71.3 |
| Financing Cost | CZK mil | 7.49 | 5.63 | 6.77 |
| Pre-Tax Profit | CZK mil | 87.2 | 53.9 | 64.5 |
| Net Profit | CZK mil | 68.6 | 41.5 | 50.5 |
| Dividends | CZK mil | ... | ... | ... |
| Balance Sheet | 2015 | 2016 | 2017 | |
| Total Assets | CZK mil | 530 | 725 | 774 |
| Non-Current Assets | CZK mil | 6.32 | 168 | 168 |
| Current Assets | CZK mil | 523 | 556 | 604 |
| Working Capital | CZK mil | 434 | 510 | 562 |
| Shareholders' Equity | CZK mil | 419 | 623 | 674 |
| Liabilities | CZK mil | 111 | 102 | 99.9 |
| Total Debt | CZK mil | 0 | 0 | 0 |
| Net Debt | CZK mil | -2.47 | -27.1 | -25.1 |
| Ratios | 2015 | 2016 | 2017 | |
| ROE | % | 17.8 | 7.97 | 7.79 |
| ROCE | % | 15.7 | 7.43 | 7.18 |
| Gross Margin | % | 14.2 | 12.5 | 13.8 |
| EBITDA Margin | % | 5.18 | 3.34 | 4.00 |
| EBIT Margin | % | 5.12 | 3.27 | 3.92 |
| Net Margin | % | 3.71 | 2.28 | 2.78 |
| Net Debt/EBITDA | -0.026 | -0.445 | -0.345 | |
| Net Debt/Equity | % | -0.588 | -4.35 | -3.73 |
| Cost of Financing | % | 68.8 | ... | ... |
| Cash Flow | 2015 | 2016 | 2017 | |
| Total Cash From Operations | CZK mil | ... | 5.72 | 57.0 |
| Total Cash From Investing | CZK mil | ... | 18.9 | -59.0 |
| Total Cash From Financing | CZK mil | ... | 0 | 0 |
| Net Change In Cash | CZK mil | ... | 24.6 | -1.98 |
| Cash Conversion Cycle | days | 93.1 | 109 | 121 |
| Cash Earnings | CZK mil | 69.8 | 42.9 | 52.0 |
| Free Cash Flow | CZK mil | ... | 24.6 | -1.98 |
Get all company financials in excel:
| summary | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| income statement | ||||||||||||||||||
| Sales | CZK mil | ... | 1,622 | 1,755 | 1,726 | 1,798 | 1,850 | |||||||||||
| Gross Profit | CZK mil | ... | 232 | 230 | 184 | 201 | 263 | |||||||||||
| EBIT | CZK mil | ... | 65.9 | 82.5 | 48.2 | 52.6 | 94.7 | |||||||||||
| Net Profit | CZK mil | ... | 49.3 | 63.4 | 27.4 | 34.9 | 68.6 | |||||||||||
| ROE | % | ... | 24.6 | 24.7 | 9.05 | 10.5 | 17.8 | |||||||||||
| EBIT Margin | % | ... | 4.06 | 4.70 | 2.79 | 2.93 | 5.12 | |||||||||||
| Net Margin | % | ... | 3.04 | 3.62 | 1.59 | 1.94 | 3.71 | |||||||||||
| Employees | 131 | 119 | 113 | 112 | 107 | |||||||||||||
| balance sheet | ||||||||||||||||||
| Total Assets | CZK mil | ... | 445 | 500 | 544 | 476 | 530 | |||||||||||
| Non-Current Assets | CZK mil | ... | 10.1 | 9.11 | 8.11 | 5.62 | 6.32 | |||||||||||
| Current Assets | CZK mil | ... | 432 | 488 | 534 | 469 | 523 | |||||||||||
| Shareholders' Equity | CZK mil | ... | 225 | 289 | 316 | 351 | 419 | |||||||||||
| Liabilities | CZK mil | ... | 219 | 211 | 228 | 125 | 111 | |||||||||||
| Non-Current Liabilities | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Current Liabilities | CZK mil | ... | 196 | 187 | 200 | 91.9 | 78.7 | |||||||||||
| Net Debt/EBITDA | ... | 1.87 | 1.39 | 2.80 | 0.353 | -0.026 | ||||||||||||
| Net Debt/Equity | % | ... | 55.8 | 40.2 | 43.6 | 5.40 | -0.588 | |||||||||||
| Cost of Financing | % | ... | ... | 4.81 | 8.10 | 4.56 | 7.78 | 68.8 | ... | ... | ||||||||
| cash flow | ||||||||||||||||||
| Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| income statement | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| income statement | ||||||||||||||||||
| Sales | CZK mil | ... | 1,622 | 1,755 | 1,726 | 1,798 | 1,850 | |||||||||||
| Cost of Goods & Services | CZK mil | ... | 1,389 | 1,525 | 1,542 | 1,597 | 1,587 | |||||||||||
| Gross Profit | CZK mil | ... | 232 | 230 | 184 | 201 | 263 | |||||||||||
| Staff Cost | CZK mil | ... | 132 | 150 | 130 | 138 | 156 | |||||||||||
| Other Cost | CZK mil | ... | 33.5 | -3.66 | 5.39 | 8.86 | 11.1 | |||||||||||
| EBITDA | CZK mil | ... | 67.1 | 83.8 | 49.2 | 53.6 | 95.9 | |||||||||||
| Depreciation | CZK mil | ... | 1.22 | 1.23 | 0.998 | 1.03 | 1.17 | |||||||||||
| EBIT | CZK mil | ... | 65.9 | 82.5 | 48.2 | 52.6 | 94.7 | |||||||||||
| Financing Cost | CZK mil | ... | 6.13 | 10.7 | 6.12 | 6.50 | 7.49 | |||||||||||
| Extraordinary Cost | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Pre-Tax Profit | CZK mil | ... | 59.7 | 71.8 | 42.1 | 46.1 | 87.2 | |||||||||||
| Tax | CZK mil | ... | 10.5 | 8.39 | 14.7 | 11.2 | 18.6 | |||||||||||
| Minorities | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Net Profit | CZK mil | ... | 49.3 | 63.4 | 27.4 | 34.9 | 68.6 | |||||||||||
| Dividends | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| growth rates | ||||||||||||||||||
| Total Revenue Growth | % | ... | ... | 17.9 | 8.18 | -1.61 | 4.15 | 2.88 | ||||||||||
| Operating Cost Growth | % | ... | ... | 147 | -11.7 | -7.57 | 9.06 | 13.5 | ||||||||||
| EBITDA Growth | % | ... | ... | 170 | 24.9 | -41.2 | 8.97 | 78.8 | ||||||||||
| EBIT Growth | % | ... | ... | 182 | 25.3 | -41.6 | 9.10 | 80.1 | ||||||||||
| Pre-Tax Profit Growth | % | ... | ... | 208 | 20.3 | -41.4 | 9.51 | 89.2 | ||||||||||
| Net Profit Growth | % | ... | ... | 321 | 28.7 | -56.9 | 27.5 | 96.7 | ||||||||||
| ratios | ||||||||||||||||||
| ROE | % | ... | 24.6 | 24.7 | 9.05 | 10.5 | 17.8 | |||||||||||
| ROCE | % | ... | ... | 13.7 | 14.8 | 5.72 | 7.46 | 15.7 | ||||||||||
| Gross Margin | % | ... | 14.3 | 13.1 | 10.7 | 11.2 | 14.2 | |||||||||||
| EBITDA Margin | % | ... | 4.14 | 4.77 | 2.85 | 2.98 | 5.18 | |||||||||||
| EBIT Margin | % | ... | 4.06 | 4.70 | 2.79 | 2.93 | 5.12 | |||||||||||
| Net Margin | % | ... | 3.04 | 3.62 | 1.59 | 1.94 | 3.71 | |||||||||||
| Payout Ratio | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| Cost of Financing | % | ... | ... | 4.81 | 8.10 | 4.56 | 7.78 | 68.8 | ... | ... | ||||||||
| Net Debt/EBITDA | ... | 1.87 | 1.39 | 2.80 | 0.353 | -0.026 |
| balance sheet | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| balance sheet | ||||||||||||||||||
| Non-Current Assets | CZK mil | ... | 10.1 | 9.11 | 8.11 | 5.62 | 6.32 | |||||||||||
| Property, Plant & Equipment | CZK mil | ... | 9.25 | 8.45 | 7.65 | 5.36 | 6.06 | |||||||||||
| Intangible Assets | CZK mil | ... | 0.851 | 0.659 | 0.459 | 0.258 | 0.261 | |||||||||||
| Current Assets | CZK mil | ... | 432 | 488 | 534 | 469 | 523 | |||||||||||
| Inventories | CZK mil | ... | 189 | 219 | 246 | 244 | 240 | |||||||||||
| Receivables | CZK mil | ... | 213 | 252 | 266 | 204 | 210 | |||||||||||
| Cash & Cash Equivalents | CZK mil | ... | 15.6 | 6.95 | 7.67 | 2.83 | 2.47 | |||||||||||
| Total Assets | CZK mil | ... | 445 | 500 | 544 | 476 | 530 | |||||||||||
| Shareholders' Equity | CZK mil | ... | 225 | 289 | 316 | 351 | 419 | |||||||||||
| Of Which Minority Interest | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Liabilities | CZK mil | ... | 219 | 211 | 228 | 125 | 111 | |||||||||||
| Non-Current Liabilities | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Long-Term Debt | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Deferred Tax Liabilities | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Current Liabilities | CZK mil | ... | 196 | 187 | 200 | 91.9 | 78.7 | |||||||||||
| Short-Term Debt | CZK mil | ... | 141 | 123 | 145 | 21.8 | 0 | |||||||||||
| Trade Payables | CZK mil | ... | 12.6 | 22.5 | 20.1 | 17.8 | 15.8 | |||||||||||
| Provisions | CZK mil | ... | 23.1 | 23.9 | 28.4 | 33.3 | 31.8 | |||||||||||
| Equity And Liabilities | CZK mil | ... | 445 | 500 | 544 | 476 | 530 | |||||||||||
| growth rates | ||||||||||||||||||
| Total Asset Growth | % | ... | ... | 25.8 | 12.5 | 8.86 | -12.5 | 11.3 | ||||||||||
| Shareholders' Equity Growth | % | ... | ... | 28.0 | 28.2 | 9.48 | 11.0 | 19.6 | ||||||||||
| Net Debt Growth | % | ... | ... | 13.5 | -7.53 | 18.5 | -86.2 | -113 | ||||||||||
| Total Debt Growth | % | ... | ... | 24.2 | -12.8 | 18.1 | -85.0 | -100 | ... | ... | ||||||||
| ratios | ||||||||||||||||||
| Total Debt | CZK mil | ... | 141 | 123 | 145 | 21.8 | 0 | |||||||||||
| Net Debt | CZK mil | ... | 126 | 116 | 138 | 18.9 | -2.47 | |||||||||||
| Working Capital | CZK mil | ... | 389 | 449 | 491 | 430 | 434 | |||||||||||
| Capital Employed | CZK mil | ... | 399 | 458 | 499 | 436 | 441 | |||||||||||
| Net Debt/Equity | % | ... | 55.8 | 40.2 | 43.6 | 5.40 | -0.588 | |||||||||||
| Cost of Financing | % | ... | ... | 4.81 | 8.10 | 4.56 | 7.78 | 68.8 | ... | ... |
| cash flow | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| cash flow | ||||||||||||||||||
| Net Profit | CZK mil | ... | 49.3 | 63.4 | 27.4 | 34.9 | 68.6 | |||||||||||
| Depreciation | CZK mil | ... | 1.22 | 1.23 | 0.998 | 1.03 | 1.17 | |||||||||||
| Non-Cash Items | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Change in Working Capital | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Capital Expenditures | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Other Investments | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Issuance Of Debt | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| ratios | ||||||||||||||||||
| Days Sales Outstanding | days | ... | 47.8 | 52.4 | 56.1 | 41.3 | 41.4 | |||||||||||
| Days Sales Of Inventory | days | ... | 49.6 | 52.5 | 58.2 | 55.8 | 55.3 | |||||||||||
| Days Payable Outstanding | days | ... | 3.30 | 5.39 | 4.75 | 4.07 | 3.63 | |||||||||||
| Cash Conversion Cycle | days | ... | 94.1 | 99.5 | 110 | 93.1 | 93.1 | |||||||||||
| Cash Earnings | CZK mil | ... | 50.5 | 64.7 | 28.4 | 35.9 | 69.8 | |||||||||||
| Free Cash Flow | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| other data | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| other data | ||||||||||||||||||
| ROA | % | ... | 12.4 | 13.4 | 5.24 | 6.84 | 13.6 | |||||||||||
| Gross Margin | % | ... | 14.3 | 13.1 | 10.7 | 11.2 | 14.2 | |||||||||||
| Employees | 131 | 119 | 113 | 112 | 107 | |||||||||||||
| Cost Per Employee | USD per month | ... | 4,745 | 5,361 | 4,886 | 4,818 | 5,091 | |||||||||||
| Cost Per Employee (Local Currency) | CZK per month | ... | 83,921 | 104,854 | 95,599 | 102,967 | 121,529 | |||||||||||
| Staff Cost (As % Of Total Cost) | % | ... | 8.48 | 8.96 | 7.72 | 7.93 | 8.89 | |||||||||||
| Effective Tax Rate | % | ... | 17.5 | 11.7 | 35.0 | 24.4 | 21.3 | |||||||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Sales from Chemistry | CZK mil | 303 | 384 | 346 | 373 | 391 | ||||||||||||
| Sales from Pharmacy | CZK mil | 1,038 | 1,115 | 1,145 | 1,186 | 1,228 | ||||||||||||
| Sales From Services | CZK mil | 271 | 247 | 222 | 225 | 223 |
Get all company financials in excel:
Merck spol. s r.o. (or Merck Czech Republic) is a Czech Republic-based subsidiary of Merck & Co. The Czech subsidiary was founded in 1991 and is involved in marketing , sale and distribution of pharmaceutical and chemical products. Merck & Co is the oldest pharmaceutical and chemical company in the world. Its roots date back to the year 1668. Now, the Company is a global health care player that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures
Merck Czech Republic has been growing its sales by a year on average in the last 5 years. EBITDA has fallen on average by 2.77% a year during that time to total of CZK 72.8 mil in 2017, or 4.00% of sales. That’s compared to 3.67% average margin seen in last five years.
The company netted CZK 50.5 mil in 2017 implying ROE of 7.79% and ROCE of 7.18%. Again, the average figures were 10.6% and 8.69%, respectively when looking at the previous 5 years.
Merck Czech Republic’s net debt amounted to CZK -25.1 mil at the end of 2017, or -3.73% of equity. When compared to EBITDA, net debt was -0.345x, down when compared to average of 0.467x seen in the last 5 years.
Helgi Library 
